Conditions: Type 2 Diabetes
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 12
Healthy volunteers: no

Brief summary:
This study will assess the pharmacokinetics of two formulations of MK-1006. The primary hypothesis of this study is that the MK-1006 area under the curve (0 to infinity) and maximum concentration after administration of a single 80 mg dose of the dry filled capsule (DFC) and film coated tablet (FCT) formulations of MK-1006 will be similar.

Detailed description:

Arms:
arm 1: Participants received a single dose of four 20 mg dry filled capsules of MK-1006 arm 2: Participants received a single dose of two 40 mg film coated tablets of MK-1006

Interventions: intervention 1: MK-1006 DFC intervention 2: MK-1006 FCT
Intervention descriptions: intervention 1: Each dry filled capsule contains 20 mg MK-1006 intervention 2: Each film coated tablet contains 40 mg of MK-1006

Protocol document: